Community Research and Development Information Service - CORDIS

H2020

OptiMalVax

Project ID: 733273
Funded under

Optimizing a deployable high efficacy malaria vaccine

From 2017-01-01 to 2021-12-31, ongoing project

Project details

Total cost:

EUR 23 701 228,75

EU contribution:

EUR 20 050 441,25

Coordinated in:

United Kingdom

Call for proposal:

H2020-SC1-2016-RTDSee other projects for this call

Funding scheme:

RIA - Research and Innovation action

Objective

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

EU contribution: EUR 13 026 666,25


University Offices, Wellington Square
OX1 2JD OXFORD
United Kingdom
Activity type: Higher or Secondary Education Establishments

Participants

Stichting Katholieke Universiteit / Radboud university medical center
Netherlands

EU contribution: EUR 4 427 500


Geert Grooteplein Noord
6525 EZ Nijmegen
Netherlands
Activity type: Higher or Secondary Education Establishments
ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands

EU contribution: EUR 1 175 000


ALBINUSDREEF 2
2333 ZA LEIDEN
Netherlands
Activity type: Higher or Secondary Education Establishments
UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6
France

EU contribution: EUR 437 500


Place Jussieu 4
75252 PARIS
France
Activity type: Higher or Secondary Education Establishments
GENOME RESEARCH LIMITED
United Kingdom

EU contribution: EUR 250 000


THE GIBBS BUILDING, EUSTON ROAD 215
NW1 2BE LONDON
United Kingdom
Activity type: Research Organisations
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT
France

EU contribution: EUR 183 775


Boulevard de Dunkerque - CS 90009 44
13572 MARSEILLE
France
Activity type: Research Organisations
STATENS SERUM INSTITUT
Denmark

EU contribution: EUR 250 000


ARTILLERIVEJ 5
2300 COPENHAGEN
Denmark
Activity type: Research Organisations
UNIVERSITE DE LAUSANNE
Switzerland

EU contribution: EUR 0


Quartier Unil-Centre Bâtiment Unicentre
1015 LAUSANNE
Switzerland
Activity type: Higher or Secondary Education Establishments
ISCONOVA AB
Sweden

EU contribution: EUR 150 000


KUNGSGATAN 109
753 18 UPPSALA
Sweden
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
EXPRES2ION BIOTECHNOLOGIES APS
Denmark

EU contribution: EUR 25 000


AGERN ALLE 1
2970 HORSHOLM
Denmark
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
IMAXIO SA
France

EU contribution: EUR 25 000


RUE SAINT ROCH 5/7
75001 PARIS
France
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
JAMES COOK UNIVERSITY
Australia

EU contribution: EUR 0


JAMES COOK UNIVERSITY
4811 TOWNSVILLE
Australia
Activity type: Higher or Secondary Education Establishments
United States Department of Health and Human Services
United States

EU contribution: EUR 25 000


Independence Avenue S. W. 200
20201 Washington D.C.
United States
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
PROGRAM FOR APPROPRIATE TECHNOLOGYIN HEALTH
United States

EU contribution: EUR 25 000


Leary WAY NW 1455
98107-5136 Seattle WA
United States
Activity type: Research Organisations
THE MEDICAL RESEARCH COUNCIL
United Kingdom

EU contribution: EUR 25 000


North Star Avenue
SN2 1FL Swindon
United Kingdom
Activity type: Research Organisations
JANSSEN VACCINES & PREVENTION BV
Netherlands

EU contribution: EUR 25 000


ARCHIMEDESWEG 4
2333 CN LEIDEN
Netherlands
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Record Number: 207225 / Last updated on: 2017-04-19